We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
–
AUM
$2.79B
AUM Growth
-$323M
Cap. Flow
-$496M
Cap. Flow %
-17.8%
Top 10 Hldgs %
54.72%
Holding
493
New
23
Increased
52
Reduced
324
Closed
50

Top Buys

Rank Stock Value
1
JPIB icon
JPMorgan International Bond Opportunities ETF
JPIB
+$8.66M
2
JCPB icon
JPMorgan Core Plus Bond ETF
JCPB
+$7.78M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.45M
4
JPEM icon
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
+$2.18M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$1.16M

Top Sells

Rank Stock Value
1
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$59.3M
2
SCHV
Schwab US Large-Cap Value ETF
SCHV
+$55M
3
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$38.2M
4
HYMB icon
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
+$17.6M
5
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 4.65%
2 Healthcare 2.39%
3 Industrials 2.32%
4 Consumer Staples 2.19%
5 Financials 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BWB icon
426
Bridgewater Bancshares
BWB
$592M
$150K 0.01%
10,600
-2,500
-19% -$33.5K
CERO
427
DELISTED
CERo Therapeutics
CERO
$127K ﹤0.01%
681
+641
+1,603% +$195K
DNP icon
428
DNP Select Income Fund
DNP
$4.05B
$113K ﹤0.01%
11,241
-663
-6% -$6.06K
NNDM
429
Nano Dimension
NNDM
$330M
$80.8K ﹤0.01%
33,000
+18,000
+120% +$40.6K
HUBC icon
430
Hub Cyber Security
HUBC
$32M
$69.8K ﹤0.01%
+1
New +$92.9K
HL icon
431
Hecla Mining
HL
$10.7B
$67.6K ﹤0.01%
+10,133
New +$59.2K
TEF
432
DELISTED
Telefonica
TEF
$56.7K ﹤0.01%
11,663
– –
SUNE
433
SUNation Energy
SUNE
$10.2M
$47.2K ﹤0.01%
+35
New +$343K
LTRN icon
434
Lantern Pharma
LTRN
$35.5M
$42.7K ﹤0.01%
11,640
– –
MIRA icon
435
MIRA Pharmaceuticals
MIRA
$28.5M
$41.6K ﹤0.01%
32,000
-86,751
-73% -$138K
PTHS
436
Pelthos Therapeutics
PTHS
$102M
$33.5K ﹤0.01%
+4,721
New +$46K
ORGO icon
437
Organogenesis Holdings
ORGO
$310M
$29.5K ﹤0.01%
10,324
– –
PLUG icon
438
Plug Power
PLUG
$2.89B
$27.5K ﹤0.01%
12,161
+1,425
+13% +$3.19K
IVP
439
DELISTED
Inspire Veterinary Partners
IVP
$27.4K ﹤0.01%
+3,440
New +$347K
ABVC icon
440
ABVC BioPharma
ABVC
$26.5M
$26.7K ﹤0.01%
39,000
– –
HITI
441
High Tide
HITI
$201M
$26.1K ﹤0.01%
12,755
– –
BLUE
442
DELISTED
bluebird bio
BLUE
$26K ﹤0.01%
+2,500
New +$41.6K
XLO icon
443
Xilio Therapeutics
XLO
$61M
$16.1K ﹤0.01%
1,463
-323
-18% -$3.96K
BLDR icon
444
Builders FirstSource
BLDR
$7.8B
– –
-1,490
Closed -$206K
CBZ icon
445
CBIZ
CBZ
$2.96B
– –
-5,000
Closed -$371K
CMG icon
446
Chipotle Mexican Grill
CMG
$42.7B
– –
-5,100
Closed -$320K
CNC icon
447
Centene
CNC
$31.7B
– –
-3,418
Closed -$227K
CVKD icon
448
Cadrenal Therapeutics
CVKD
$6.67M
– –
-7,554
Closed -$53.3K
CVS icon
449
CVS Health
CVS
$123B
– –
-4,366
Closed -$258K
DAL icon
450
Delta Air Lines
DAL
$60.5B
– –
-4,652
Closed -$221K
16 17
18
19 20

Similar funds

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return

Avantax Planning Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Avantax Planning Partners held 493 positions worth $2.79B, down 10% from $3.11B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Avantax Planning Partners withdrew a net $496M in Q3 2024, closing 50 positions and reducing 324 holdings. Its most notable exit was iShares iBonds Dec 2028 Term Corporate ETF, an estimated $2.14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Avantax Planning Partners opened a new position in Vertex Pharmaceuticals worth $397K.

  • Avantax Planning Partners's largest Q3 2024 buy was Vertex Pharmaceuticals: 854 shares worth $397K.
  • Avantax Planning Partners added most to JPMorgan International Bond Opportunities ETF in Q3 2024, an estimated $8.66M increase.
  • Avantax Planning Partners's biggest Q3 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $59.3M.
  • Avantax Planning Partners fully exited iShares iBonds Dec 2028 Term Corporate ETF in Q3 2024, selling an estimated $2.14M.
  • Avantax Planning Partners's ten largest holdings make up 55% of its $2.79B portfolio in Q3 2024.
  • Avantax Planning Partners opened 23 new positions and closed 50 in Q3 2024.
  • Avantax Planning Partners's portfolio value fell 10% quarter-over-quarter to $2.79B.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.